We welcome you to join us at the heart of the Finnish Lakeland for our three-day symposium Computational and Medicinal Chemistry by the Lake 2026 from the 2nd to the 4th of June in Kuopio, Finland. Together, we will be diving into the latest innovations in drug discovery in both academia and industry.
Our Plenary, Keynote and Invited talks from some of the top researchers in computational medicinal chemistry, medicinal chemistry, and drug discovery will showcase the best and brightest ideas for the modern-day medicinal chemistry toolbox, giving insights into key decision-making events and specific case studies.
Whatever your interest – PROTACs, Molecular glues, Structure-based drug design, Molecular dynamics, Ultra-large-scale virtual screening, ML and AI – We will be talking about it!
Confirmed speakers
Keynote speakers
- Ilpo Vattulainen, University of Helsinki, Finland
- Jian Jin, Icahn School of Medicine at Mount Sinai, United States
- Matthias Rarey, University of Hamburg, Germany
- Rebecca Wade, Heidelberg Institute for Theoretical Studies & Heidelberg University, Germany
- Stefan Knapp, Goethe University Frankfurt & Structural Genomics Consortium (SGC), Frankfurt, Germany
- Yves Auberson, Novartis Institutes for Biomedical research, Switzerland
Invited speakers
- Aniket Magarkar, Boehringer Ingelheim, Germany
- Daniel Merk, Ludwig-Maximilians-Universität München, Germany
- Eva Nittinger, AstraZeneca, Sweden
- Gabriele Cruciani, University of Perugia, Italy
- Heikki Käsnänen, Orion Pharma, Finland
- John Scott, Monash University, Australia
- Marcus Hartmann, Max Planck Institute for Biology Tübingen, Germany
- Matthew Robers, Promega, United States
- Mikko Karttunen, University of Eastern Finland, Finland
- Roman Sarott, Max Planck Institute for Medical Research, Germany
- Simona Collina, University of Pavia, Italy
- Stefan Laufer, University of Tübingen, Germany
- Thierry Langer, University of Vienna, Austria
- Zoe Cournia, Academy of Athens, Greece
Who should attend?
This conference is for academics, industry professionals and students involved in the wider drug discovery community. This includes but is not limited to – medicinal chemistry, chemical biology, pharmacy, biochemistry and assay development, computational modelling, computer-aided drug discovery and computational biology.
